Product Code: IRTNTR3648
About Contraceptives
Contraception, also known as birth control or fertility control, refers to the
use of methods or drugs or devices to prevent pregnancy as a consequence of
sexual intercourse. Contraception methods can be temporary and permanent and
are available to men and women. Permanent methods include male sterilization
(vasectomy), and female sterilization including tubal occlusion or
hysteroscopic sterilisation. Temporary methods can be hormonal and
non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges,
withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms,
sponges, and cervical caps are also referred to as barrier contraception
methods. Hormonal methods include oral contraceptive pills, contraceptive
transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants.
Hormonal methods contain synthetic sex hormones estrogen/progestin or a
combination of both which prevent ovulation and thicken cervical mucus in the
female. Currently, hormonal methods can only be used by women. The development
of a male hormonal contraceptive is an active research area.
TechNavio's analysts forecast the Global Contraceptives market will grow at a
CAGR of 5.90 percent over the period 2013-2018.
Covered in this Report
The Global Contraceptives market can be segmented broadly into two divisions:
Drugs and Devices. This report covers the present scenario and the growth
prospects of the Global Contraceptives market for the period 2013-2018. To
calculate the market size, the report considers revenue generated from the
sales of various products used for contraception which include:
Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical
Contraceptives)
Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female
Sponges and Subdermal Contraceptive Implants)
TechNavio's report, the Global Contraceptives Market 2014-2018, has been
prepared based on an in-depth market analysis with inputs from industry
experts. The report covers the Americas, and the EMEA and APAC regions; it
also covers the Global Contraceptives market landscape and its growth
prospects in the coming years. The report also includes a discussion of the
key vendors operating in this market.
Key Regions
Key Vendors
- Actavis plc
- Bayer AG
- Johnson & Johnson's Janssen Pharmaceuticals, Inc.
- Merck & Co.
- Pfizer, Inc.
- Teva Pharmaceutical Industries, Ltd
Other Prominent Vendors
- Adamis Pharmaceuticals
- Corp.
- Agile Therapeutics, Inc.
- ANI Pharmaceuticals, Inc.
- Ansell Ltd.
- Apothecus Pharmaceutical Corp.
- Blairex Laboratories Inc.
- Church & Dwight, Co. Inc.
- Caldwell Consumer Health, LLC.
- Ferring International Center S.A
- Fuji Latex Co., Ltd.
- HLL Lifecare Limited
- Mayer Laboratories
- Medicines 360
- Karex Berhad
- Lipocine Inc.
- Lupin Pharmaceuticals, Inc.
- Mylan Laboratories Inc.
- Okamoto Industries, Inc.
- Pantarhei Bioscience B.V.
- Paul Hartmann AG
- Reckitt Benckiser Group Plc
- The Female Health Company
Key Market Driver
- Growing Prevalence of Unwanted Pregnancies.
For a full, detailed list, view our report.
Key Market Challenge
- Growing Prevalence of Unwanted Pregnancies.
- Introduction of Cheap Generic Contraceptives
For a full, detailed list, view our report.
Key Market Trend
- Increasing Strategic Partnerships.
For a full, detailed list, view our report.
Key questions answered in this report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this
market report. Details are provided within the report.
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
- 03.1. Market Overview
- 03.2. Product Offerings
04. Market Research Methodology
- 04.1. Market Research Process
- 04.2. Research Methodology
05. Introduction
06. Market Landscape
- 06.1. Market Overview
- 06.2. Market Size and Forecast
- 06.3. Five Forces Analysis
07. Market Segmentation by Products Type
- 07.1.1. Drugs
- 07.1.2. Devices
- 07.1.3. Comparison of Different Types of Contraceptives
08. Global Contraceptives Drugs Market
- 08.1. Market Size and Forecast of Contraceptives Drugs
- 08.2. Global Oral Contraceptives Pills Market
- 08.2.1. Market Size and Forecast of Oral Contraceptives Pills
- 08.3. Global Injectable Contraceptives Market
- 08.3.1. Market Size and Forecast of Injectable Contraceptives
- 08.4. Global Topical Contraceptives Market
- 08.4.1. Market Size and Forecast of Topical Contraceptives
09. Global Contraceptives Devices Market
- 09.1. Market Size and Forecast of Contraceptives Devices
- 09.2. Global Condoms Market
- 09.2.1. Market Size and Forecast of Condoms
- 09.3. Global IUDs Market
- 09.3.1. Market Size and Forecast of IUDs
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Vendor Landscape
- 19.1. Competitive Scenario
- 19.1.1. Key News
- 19.1.2. Mergers and Acquisitions
- 19.2. Market Share Analysis 2013
- 19.3. Other Prominent Vendors
20. Key Vendor Analysis
21. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Market Research Methodology
- Exhibit 2: Global Contraceptives Market 2013-2018 (US$ billion)
- Exhibit 3: Global Contraceptives Market Segmentation by Product Type
- Exhibit 4: Global Contraceptives Market by Product Type 2013
- Exhibit 5: Global Contraceptives Market Segmentation by Product Type
- Exhibit 6: Global Contraceptives Drugs Market Segmentation
- Exhibit 7: Global Contraceptives Drugs Market 2013-2018 (US$ billion)
- Exhibit 8: Global Oral Contraceptives Pills Market 2013-2018 (US$ billion)
- Exhibit 9: Global Injectable Contraceptives Market 2013-2018 (US$ billion)
- Exhibit 10: Global Topical Contraceptives Market 2013-2018 (US$ billion)
- Exhibit 11: Global Contraceptives Drugs Market 2013-2018 (US$ billion)
- Exhibit 12: Global Contraceptives Drugs Market 2013-2018 (Revenue in
Percentage)
- Exhibit 13: Global Contraceptives Devices Market Segmentation
- Exhibit 14: Global Contraceptives Devices Market 2013-2018 (US$ billion)
- Exhibit 15: Global Condoms Market 2013-2018 (US$ billion)
- Exhibit 16: Global Contraceptives Market by Geographical Segmentation
(Revenue in Percentage)
- Exhibit 17: Snapshot of Global Contraceptives Market Pipeline 2013
- Exhibit 18: Licensing Agreements in Global Contraceptives Market (in
Percentage)
